Jump to content

Inequalities in access to dementia care and treatment across Europe


Monday 10 Jul 2017

Alzheimer Europe’s European Parliament lunch debate on 26th June focused on current and future treatment of Alzheimer’s dementia.

New Alzheimer Europe publication highlights inequalities in access to dementia care and treatment across Europe

The numbers of people with dementia in Europe is increasing and still there is no cure for Alzheimer’s disease (AD) or any other common type of dementia. Medicines have been developed for AD that can temporarily alleviate symptoms, or slow down their progression, in some people but these treatments have limited efficacy. Yet despite an unprecedented research focus on AD and dementia at European and global level, attempts to develop new drugs for treating Alzheimer’s disease have so far been unsuccessful. However our understanding of the underlying disease processes causing Alzheimer’s dementia has increased. The four speakers at the lunch debate presented an overview of past present and future treatment and research into treatments for AD.

Alzheimer Europe Report

Event was hosted by Deirdre Clune MEP and speakers included Helen Rochford Brennan, Chairperson of the European Working Group of People with Dementia.